Skip to main content
OpenTrials
Completed

NCT Number: NCT06232590

Performance Comparison of Two Monthly Replacement Silicone Hydrogel Multifocal Lens Types

To evaluate and compare the performance of two monthly replacement multifocal contact lenses in existing wearers.

Completed

Looking for future studies?

Notify Me

Key information

Age range

42 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Spadina Optometry, Toronto, Ontario, Canada

Loading trial locations.

About this study

This was a prospective, randomized, participant-masked, crossover, bilateral dispensing study. Each lens type was worn for approximately 4-6 weeks: the lens prescription of each lens type was optimized after 3-10 days wearing experience, prior to starting a 1-month (28-32 days) wear period.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Were at least 42 years of age and had full legal capacity to volunteer;
  • Had read and signed an information consent letter;
  • Self-reported having had a full eye examination in the previous two years;
  • Anticipated being able to wear the study lenses for at least 8 hours a day, 5 days a week;
  • Were willing and able to follow instructions and maintain the appointment schedule;
  • Habitually wore spherical multifocal soft contact lenses, for the past 3 months minimum:
  • Maximum of 4 participants (out of 12) per site could be habitual wearers of daily disposable lenses,
  • Maximum of 4 participants (out of 12) per site could be habitual wearers of Biofinity Multifocal,
  • Maximum of 4 participants (out of 12) per site could be habitual wearers of either TOTAL30 Multifocal or AirOptix plus HydraGlyde Multifocal
  • Had refractive astigmatism no higher than -0.75DC;
  • Is presbyopic and requires a reading addition of at least +0.75D and no more than +2.50D;
  • Could be fit and achieve binocular distance vision of at least 20/30 Snellen which participants also deem to be 'acceptable', with the available study lens parameters (Distance sphere +4 to -6; near addition as per study design).

Exclusion criteria

  • Were participating in any concurrent clinical or research study;
  • Had any known active ocular disease and/or infection that contraindicated contact lens wear;
  • Had a systemic or ocular condition that in the opinion of the investigator may have affected a study outcome variable;
  • Were using any systemic or topical medications that in the opinion of the investigator may have affect contact lens wear or a study outcome variable;
  • Had known sensitivity to the diagnostic sodium fluorescein used in the study;
  • Self-reported as pregnant, lactating or planning a pregnancy at the time of enrolment;
  • Had undergone refractive error surgery or intraocular surgery.

Treatment and study plan

Control Lens (comfilcon A)

Device

Multifocal monthly replacement contact lens for 1 month

Test Lens (lehfilcon A)

Device

Multifocal monthly replacement contact lens for 1 month

Primary outcomes

  1. Lens Handling for Insertion

    Time frame: 1 month

    Subjective rating collected in office using a 0-100 scale, where 0=Very difficult and 100=Very easy. The participant rated the study lens considering a typical day in the last 1 month of wear.

Sponsors and collaborators

Lead sponsor

CooperVision International Limited (CVIL)

Industry

Collaborators

  • Centre for Ocular Research & Education, Canada

Registry information

Important dates

Study start
2024
Primary completion
2024
Study completion
2024
First posted
Jan 31, 2024
Registry last updated
Feb 12, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.